Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex - PubMed (original) (raw)
Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex
M J May et al. Science. 2000.
Abstract
Activation of the transcription factor nuclear factor (NF)-kappaB by proinflammatory stimuli leads to increased expression of genes involved in inflammation. Activation of NF-kappaB requires the activity of an inhibitor of kappaB (IkappaB)-kinase (IKK) complex containing two kinases (IKKalpha and IKKbeta) and the regulatory protein NEMO (NF-kappaB essential modifier). An amino-terminal alpha-helical region of NEMO associated with a carboxyl-terminal segment of IKKalpha and IKKbeta that we term the NEMO-binding domain (NBD). A cell-permeable NBD peptide blocked association of NEMO with the IKK complex and inhibited cytokine-induced NF-kappaB activation and NF-kappaB-dependent gene expression. The peptide also ameliorated inflammatory responses in two experimental mouse models of acute inflammation. The NBD provides a target for the development of drugs that would block proinflammatory activation of the IKK complex without inhibiting basal NF-kappaB activity.
Similar articles
- The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis.
Dai S, Hirayama T, Abbas S, Abu-Amer Y. Dai S, et al. J Biol Chem. 2004 Sep 3;279(36):37219-22. doi: 10.1074/jbc.C400258200. Epub 2004 Jul 13. J Biol Chem. 2004. PMID: 15252035 - NEMO-binding domains of both IKKalpha and IKKbeta regulate IkappaB kinase complex assembly and classical NF-kappaB activation.
Solt LA, Madge LA, May MJ. Solt LA, et al. J Biol Chem. 2009 Oct 2;284(40):27596-608. doi: 10.1074/jbc.M109.047563. Epub 2009 Aug 7. J Biol Chem. 2009. PMID: 19666475 Free PMC article. - Regulation and function of IKK and IKK-related kinases.
Häcker H, Karin M. Häcker H, et al. Sci STKE. 2006 Oct 17;2006(357):re13. doi: 10.1126/stke.3572006re13. Sci STKE. 2006. PMID: 17047224 Review. - Characterization of the Ikappa B-kinase NEMO binding domain.
May MJ, Marienfeld RB, Ghosh S. May MJ, et al. J Biol Chem. 2002 Nov 29;277(48):45992-6000. doi: 10.1074/jbc.M206494200. Epub 2002 Sep 19. J Biol Chem. 2002. PMID: 12244103 - Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.
Karin M, Ben-Neriah Y. Karin M, et al. Annu Rev Immunol. 2000;18:621-63. doi: 10.1146/annurev.immunol.18.1.621. Annu Rev Immunol. 2000. PMID: 10837071 Review.
Cited by
- Cell-penetrating peptides: Possible transduction mechanisms and therapeutic applications.
Guo Z, Peng H, Kang J, Sun D. Guo Z, et al. Biomed Rep. 2016 May;4(5):528-534. doi: 10.3892/br.2016.639. Epub 2016 Mar 23. Biomed Rep. 2016. PMID: 27123243 Free PMC article. - Use of cell permeable NBD peptides for suppression of inflammation.
Strickland I, Ghosh S. Strickland I, et al. Ann Rheum Dis. 2006 Nov;65 Suppl 3(Suppl 3):iii75-82. doi: 10.1136/ard.2006.058438. Ann Rheum Dis. 2006. PMID: 17038479 Free PMC article. Review. - Post-formulation peptide drug loading of nanostructures for metered control of NF-κB signaling.
Pan H, Ivashyna O, Sinha B, Lanza GM, Ratner L, Schlesinger PH, Wickline SA. Pan H, et al. Biomaterials. 2011 Jan;32(1):231-8. doi: 10.1016/j.biomaterials.2010.08.080. Biomaterials. 2011. PMID: 20864161 Free PMC article. - Novel insights into the cellular mechanisms of the anti-inflammatory effects of NF-kappaB essential modulator binding domain peptides.
Baima ET, Guzova JA, Mathialagan S, Nagiec EE, Hardy MM, Song LR, Bonar SL, Weinberg RA, Selness SR, Woodard SS, Chrencik J, Hood WF, Schindler JF, Kishore N, Mbalaviele G. Baima ET, et al. J Biol Chem. 2010 Apr 30;285(18):13498-506. doi: 10.1074/jbc.M109.099895. Epub 2010 Feb 18. J Biol Chem. 2010. PMID: 20167598 Free PMC article. - Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy.
Acharyya S, Villalta SA, Bakkar N, Bupha-Intr T, Janssen PM, Carathers M, Li ZW, Beg AA, Ghosh S, Sahenk Z, Weinstein M, Gardner KL, Rafael-Fortney JA, Karin M, Tidball JG, Baldwin AS, Guttridge DC. Acharyya S, et al. J Clin Invest. 2007 Apr;117(4):889-901. doi: 10.1172/JCI30556. Epub 2007 Mar 22. J Clin Invest. 2007. PMID: 17380205 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous